AU2006205696C1 - IL-10 related peptides for wound healing - Google Patents

IL-10 related peptides for wound healing Download PDF

Info

Publication number
AU2006205696C1
AU2006205696C1 AU2006205696A AU2006205696A AU2006205696C1 AU 2006205696 C1 AU2006205696 C1 AU 2006205696C1 AU 2006205696 A AU2006205696 A AU 2006205696A AU 2006205696 A AU2006205696 A AU 2006205696A AU 2006205696 C1 AU2006205696 C1 AU 2006205696C1
Authority
AU
Australia
Prior art keywords
wound
scar
wounds
peptide
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2006205696A
Other languages
English (en)
Other versions
AU2006205696A1 (en
AU2006205696B2 (en
Inventor
Amanda Deakin
Mark W. J. Ferguson
Sharon O'kane
Nick Occleston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Renovo Ltd
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Publication of AU2006205696A1 publication Critical patent/AU2006205696A1/en
Application granted granted Critical
Publication of AU2006205696B2 publication Critical patent/AU2006205696B2/en
Publication of AU2006205696C1 publication Critical patent/AU2006205696C1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2006205696A 2005-01-13 2006-01-06 IL-10 related peptides for wound healing Ceased AU2006205696C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0500643.2A GB0500643D0 (en) 2005-01-13 2005-01-13 Medicaments
GB0500643.2 2005-01-13
PCT/GB2006/000051 WO2006075138A2 (en) 2005-01-13 2006-01-06 Il-10 related peptides for wound healing

Publications (3)

Publication Number Publication Date
AU2006205696A1 AU2006205696A1 (en) 2006-07-20
AU2006205696B2 AU2006205696B2 (en) 2011-09-01
AU2006205696C1 true AU2006205696C1 (en) 2012-01-19

Family

ID=34224534

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006205696A Ceased AU2006205696C1 (en) 2005-01-13 2006-01-06 IL-10 related peptides for wound healing

Country Status (7)

Country Link
US (3) US20080139478A1 (enExample)
EP (2) EP2332566A1 (enExample)
JP (2) JP2008526935A (enExample)
AU (1) AU2006205696C1 (enExample)
CA (1) CA2594798A1 (enExample)
GB (1) GB0500643D0 (enExample)
WO (1) WO2006075138A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0500643D0 (en) 2005-01-13 2005-02-23 Renovo Ltd Medicaments
RU2542471C2 (ru) * 2006-11-15 2015-02-20 Коуда Терапьютикс, Инк. Улучшенные способы и композиции для заживления ран
EP2451780B1 (en) 2009-07-06 2013-06-19 AstraZeneca AB Intermediates and processes for the preparation of 4-(acetylamino))-3-[(4-chloro-phenyl)thio]-2-methyl-1h-indole-1-acetic acid
EP2691515A2 (en) * 2011-03-31 2014-02-05 President and Fellows of Harvard College A unique population of regulatory t cells that regulate tissue regeneration and wound healing
US20160287744A1 (en) 2012-11-14 2016-10-06 3-D Matrix Ltd. Vascular embolic system
CA2905182A1 (en) * 2013-03-14 2014-09-18 3-D Matrix, Ltd. Materials for gastrointestinal obstruction prevention
EP2986306A4 (en) 2013-04-18 2016-12-07 Armo Biosciences Inc METHOD FOR USE OF INTERLEUKIN-10 FOR THE TREATMENT OF ILLNESSES AND SUFFERING
CA2914837A1 (en) 2013-06-17 2014-12-24 Armo Biosciences, Inc. Method for assessing protein identity and stability
US10098929B2 (en) 2013-08-02 2018-10-16 Children's Hospital Medical Center Method of reducing scar formation in healing of dermal wounds by administering interleukin-10 and hyaluronan
US10010588B2 (en) 2013-08-30 2018-07-03 Armo Biosciences, Inc. Methods of using pegylated interleukin-10 for treating hyperlipidemia
KR20160079114A (ko) 2013-11-11 2016-07-05 아르모 바이오사이언시스 인코포레이티드 질환 및 장애를 치료하기 위한 인터류킨-10을 사용하는 방법
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
EP3206713A4 (en) 2014-10-14 2018-06-27 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
AU2015336101A1 (en) 2014-10-22 2017-04-20 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10618970B2 (en) 2015-02-03 2020-04-14 Armo Biosciences, Inc. Method of treating cancer with IL-10 and antibodies that induce ADCC
WO2016191587A1 (en) 2015-05-28 2016-12-01 Armo Biosciences, Inc. Pegylated interleukin-10 for use in treating cancer
CA2995120A1 (en) 2015-08-25 2017-03-02 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128447A1 (en) * 1995-08-09 2002-09-12 Renovo Limited Pharmaceutical composition containing IL-10

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6217857B1 (en) * 1989-06-28 2001-04-17 Schering Corporation Cytokine synthesis inhibitory factor (IL-10) and pharmaceutical compositions thereof
MX9606537A (es) * 1994-07-05 1997-12-31 Steeno Res Group As Inmunomoduladores.
WO1997026278A1 (en) * 1996-01-18 1997-07-24 Steeno Research Group A/S Synthetic il-10 analogues
GB0500643D0 (en) 2005-01-13 2005-02-23 Renovo Ltd Medicaments

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128447A1 (en) * 1995-08-09 2002-09-12 Renovo Limited Pharmaceutical composition containing IL-10

Also Published As

Publication number Publication date
AU2006205696A1 (en) 2006-07-20
HK1105366A1 (en) 2008-02-15
WO2006075138A2 (en) 2006-07-20
US20120238505A1 (en) 2012-09-20
EP2332566A1 (en) 2011-06-15
EP1858544A2 (en) 2007-11-28
CA2594798A1 (en) 2006-07-20
US20150218222A1 (en) 2015-08-06
WO2006075138A3 (en) 2006-10-19
JP2012211185A (ja) 2012-11-01
JP2008526935A (ja) 2008-07-24
GB0500643D0 (en) 2005-02-23
US20080139478A1 (en) 2008-06-12
EP1858544B1 (en) 2014-03-05
AU2006205696B2 (en) 2011-09-01

Similar Documents

Publication Publication Date Title
US20150218222A1 (en) Medicaments
EP2359844A2 (en) Medicaments and proteins based on TGF-beta monomers for the treatment of wounds
WO1998036061A2 (en) Reducing fibrosis and/or scarring by inhibiting interleukin-6 receptor-mediated activity
EP0941108B1 (en) Wound healing and treatment of fibrosis
US20110212897A1 (en) Wnt3a for inhibition of scarring
EP2566483A1 (en) Methods and agents for enhancing wound healing
BRPI0708785A2 (pt) proteÍnas, Ácidos nuclÉicos e medicamentos
US20100137201A1 (en) Medicaments
US20100261659A1 (en) Secreted frizzled related protein 3 for use in the inhibition of scarring
HK1105366B (en) Il-10 related peptides for wound healing
HK1158509A (en) Il-10 related peptides for wound healing
JP2010535184A (ja) 非眼瘢痕の抑制に使用できる薬剤および方法

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 12 SEP 2011.

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 12 SEP 2011

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired